CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 8,400 target
Drug / intervention
Familial risk assessment and personalized prevention messagesbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00164658
NCT00164658Phase 1Completed
CompareCT.gov

Evaluating Tools for Health Promotion and Disease Prevention

Centers for Disease Control and Prevention·interventional·Posted Sep 14, 2005·Updated Jan 7, 2010

In Brief

A Phase 1 clinical trial evaluating Familial risk assessment and personalized prevention messages for Coronary Heart Disease and 5 related conditions. Completed, enrolled 8,400 participants across 3 sites.

Detailed Summary

The study will evaluate the effect of familial risk assessment and prevention prompts tailored to familial risk on health behaviors and use of preventive services among adults who are members of primary care practices in the U.S.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Heart Disease, Stroke, Diabetes, Breast Cancer, Ovarian Cancer, Colorectal Cancer
CountriesUnited States
CollaboratorsCase Western Reserve University, American Academy of Family Physicians National Research Network, Evanston Northwestern Healthcare Research Institute, University of Michigan

Timeline

Phase 1CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 14, 2005
Enrollment StartSep 1, 2005
Study CompletionOct 1, 2007
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

Familial risk assessment and personalized prevention messagesbehavioral